TY - JOUR
T1 - Preventing Small-for-size Syndrome in Living Donor Liver Transplantation
T2 - Guidelines from the ILTS-iLDLT-LTSI Consensus Conference
AU - Hakeem, Abdul Rahman
AU - Mathew, Johns Shaji
AU - Aunés, Carmen Vinaixa
AU - Mazzola, Alessandra
AU - Alconchel, Felipe
AU - Yoon, Young In
AU - Testa, Giuliano
AU - Selzner, Nazia
AU - Sarin, Shiv Kumar
AU - Lee, Kwang Woong
AU - Soin, Arvinder
AU - Pomposelli, James
AU - Menon, Krishna
AU - Goyal, Neerav
AU - Kota, Venugopal
AU - Abu-Gazala, Samir
AU - Rodriguez-Davalos, Manuel
AU - Rajalingam, Rajesh
AU - Kapoor, Dharmesh
AU - Durand, Francois
AU - Kamath, Patrick
AU - Jothimani, Dinesh
AU - Sudhindran, Surendran
AU - Vij, Vivek
AU - Yoshizumi, Tomoharu
AU - Egawa, Hiroto
AU - Lerut, Jan
AU - Broering, Dieter
AU - Berenguer, Marina
AU - Cattral, Mark
AU - Clavien, Pierre Alain
AU - Chen, Chao Long
AU - Shah, Samir
AU - Zhu, Zhi Jun
AU - Ascher, Nancy
AU - Bhangui, Prashant
AU - Rammohan, Ashwin
AU - Emond, Jean
AU - Rela, Mohamed
N1 - Publisher Copyright:
© 2023 Lippincott Williams and Wilkins. All rights reserved.
PY - 2023/10/1
Y1 - 2023/10/1
N2 - Small-for-size syndrome (SFSS) is a well-recognized complication following liver transplantation (LT), with up to 20% developing this following living donor LT (LDLT). Preventing SFSS involves consideration of factors before the surgical procedure, including donor and recipient selection, and factors during the surgical procedure, including adequate outflow reconstruction, graft portal inflow modulation, and management of portosystemic shunts. International Liver Transplantation Society, International Living Donor Liver Transplantation Group, and Liver Transplant Society of India Consensus Conference was convened in January 2023 to develop recommendations for the prediction and management of SFSS in LDLT. The format of the conference was based on the Grading of Recommendations, Assessment, Development, and Evaluation system. International experts in this field were allocated to 4 working groups (diagnosis, prevention, anesthesia, and critical care considerations, and management of established SFSS). The working groups prepared evidence-based recommendations to answer-specific questions considering the currently available literature. The working group members, independent panel, and conference attendees served as jury to edit and confirm the final recommendations presented at the end of the conference by each working group separately. This report presents the final statements and evidence-based recommendations provided by working group 2 that can be implemented to prevent SFSS in LDLT patients.
AB - Small-for-size syndrome (SFSS) is a well-recognized complication following liver transplantation (LT), with up to 20% developing this following living donor LT (LDLT). Preventing SFSS involves consideration of factors before the surgical procedure, including donor and recipient selection, and factors during the surgical procedure, including adequate outflow reconstruction, graft portal inflow modulation, and management of portosystemic shunts. International Liver Transplantation Society, International Living Donor Liver Transplantation Group, and Liver Transplant Society of India Consensus Conference was convened in January 2023 to develop recommendations for the prediction and management of SFSS in LDLT. The format of the conference was based on the Grading of Recommendations, Assessment, Development, and Evaluation system. International experts in this field were allocated to 4 working groups (diagnosis, prevention, anesthesia, and critical care considerations, and management of established SFSS). The working groups prepared evidence-based recommendations to answer-specific questions considering the currently available literature. The working group members, independent panel, and conference attendees served as jury to edit and confirm the final recommendations presented at the end of the conference by each working group separately. This report presents the final statements and evidence-based recommendations provided by working group 2 that can be implemented to prevent SFSS in LDLT patients.
UR - http://www.scopus.com/inward/record.url?scp=85172425798&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85172425798&partnerID=8YFLogxK
U2 - 10.1097/TP.0000000000004769
DO - 10.1097/TP.0000000000004769
M3 - Article
C2 - 37635285
AN - SCOPUS:85172425798
SN - 0041-1337
VL - 107
SP - 2203
EP - 2215
JO - Transplantation
JF - Transplantation
IS - 10
ER -